BBNX Beta Bionics, Inc.

Fundamentals / CIK 0001674632 / USD

Beta Bionics, Inc. reported $127.3M in revenue and a net loss of $83.12M for the trailing twelve months ended September 30, 2026 (up 30.3% year over year), with a 58.6% gross margin and a -72.7% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open BBNX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

3 fiscal years (2023 to 2025), reported in USD.

$106.5M$53.27M$0-$76.96MFY 2023 Revenue: $11.99MFY 2023 Net Income: -$44.10M2023FY 2024 Revenue: $65.12MFY 2024 Net Income: -$54.76M2024FY 2025 Revenue: $100.3MFY 2025 Net Income: -$73.20M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31
Revenue $100.3M $65.12M $11.99M
Cost of Revenue $44.71M $29.24M $5.69M
Gross Profit $55.54M $35.89M $6.31M
Research & Development $34.79M $26.18M $17.94M
Selling, General & Admin $92.43M $54.95M $24.21M
Total Operating Expenses $127.2M $81.14M $42.16M
Operating Income -$71.68M -$45.25M -$35.85M
EBITDA -$70.11M -$44.10M -$34.62M
Interest Income $10.93M $3.91M $1.78M
Income Tax Expense $0 $0 --
Net Income -$73.20M -$54.76M -$44.10M
Basic EPS -$1.81 -$8.60 -$16.37
Diluted EPS -$1.81 -$8.60 -$16.37
Basic Shares Outstanding 40.5M 6.4M 2.7M
Diluted Shares Outstanding 40.5M 6.4M 2.7M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $35.51M $32.01M $27.63M $32.12M $27.25M $23.24M $17.64M $20.44M
Cost of Revenue $15.17M $13.11M $11.19M $13.18M $12.13M $10.73M $8.67M $8.75M
Gross Profit $20.33M $18.90M $16.44M $18.94M $15.12M $12.50M $8.97M $11.69M
Research & Development $11.97M $10.24M $10.36M $10.13M $8.20M $8.87M $7.59M $9.21M
Selling, General & Admin $34.97M $34.24M $30.35M $24.94M $23.97M $23.50M $20.02M $15.51M
Total Operating Expenses $46.94M $44.48M $40.71M $35.07M $32.16M $32.38M $27.61M $24.73M
Operating Income -$26.61M -$25.58M -$24.27M -$16.12M -$17.04M -$19.87M -$18.64M -$13.04M
EBITDA -$25.72M -$24.87M -$23.69M -$15.59M -$16.66M -$19.52M -$18.34M -$12.80M
Interest Income $2.26M $2.18M $2.38M $2.66M $2.83M $3.00M $2.44M $951K
Net Income -$24.35M -$23.40M -$21.89M -$13.47M -$14.21M -$16.87M -$28.66M -$18.11M
Basic EPS -$0.52 -$0.53 -$0.49 -- -$0.33 -$0.39 -$0.93 --
Diluted EPS -$0.52 -$0.53 -$0.49 -- -$0.33 -$0.39 -$0.93 --
Basic Shares Outstanding 46.5M 44.5M 44.4M -- 43.6M 43.4M 30.7M --
Diluted Shares Outstanding 46.5M 44.5M 44.4M -- 43.6M 43.4M 30.7M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $31.58M $30.43M $26.57M
Short-Term Investments $187.5M $73.14M $70.18M
Cash & Short-Term Investments $219.1M $103.6M $96.75M
Accounts Receivable, Net $17.12M $12.00M $4.45M
Inventory $21.72M $13.32M $1.25M
Other Current Assets -- $817K $275K
Total Current Assets $267.9M $132.9M $103.6M
Property, Plant & Equipment, Net $8.60M $4.78M $2.48M
Long-Term Investments $45.43M -- --
Other Non-Current Assets $180K $150K $121K
Total Non-Current Assets $60.84M $16.72M $6.42M
Total Assets $328.7M $149.6M $110.0M
Accounts Payable $5.00M $2.85M $1.17M
Deferred Revenue (Current) $1.56M $939K $87K
Total Current Liabilities $30.92M $21.15M $10.61M
Deferred Revenue (Non-Current) $3.30M $1.86M $255K
Other Non-Current Liabilities $1.55M -- --
Total Non-Current Liabilities $10.21M $52.48M $40.83M
Total Liabilities $41.13M $73.63M $51.43M
Total Debt (incl. Leases) $7.30M $7.25M $4.22M
Common Stock $4.0K $1.0K --
Retained Earnings -$369.9M -$296.7M -$229.7M
Accumulated Other Comp. Income $403K $65K $137K
Total Stockholders' Equity $287.6M -$245.4M -$203.1M
Total Equity $287.6M -$245.4M -$203.1M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $81.55M $44.32M $30.21M $31.58M $38.48M $35.08M $42.45M $30.43M
Short-Term Investments $158.7M $136.2M $169.3M $187.5M $190.2M $214.6M $189.0M $73.14M
Cash & Short-Term Investments $240.2M $180.5M $199.5M $219.1M $228.7M $249.7M $231.5M $103.6M
Accounts Receivable, Net $20.67M $18.05M $15.75M $17.12M $11.54M $11.39M $9.06M $12.00M
Inventory $22.97M $23.92M $23.73M $21.72M $20.37M $17.32M $15.73M $13.32M
Other Current Assets -- -- -- -- $265K $260K $260K $817K
Total Current Assets $292.9M $231.0M $248.0M $267.9M $270.0M $286.1M $261.9M $132.9M
Property, Plant & Equipment, Net $11.76M $10.75M $10.16M $8.60M $7.38M $6.46M $5.51M $4.78M
Long-Term Investments $133.4M $44.65M $39.87M $45.43M $45.33M $31.15M $64.00M --
Other Non-Current Assets $212K $141K $181K $180K $183K $144K $146K $150K
Total Non-Current Assets $150.8M $61.35M $56.43M $60.84M $60.02M $43.90M $76.11M $16.72M
Total Assets $443.8M $292.4M $304.4M $328.7M $330.0M $330.0M $338.0M $149.6M
Accounts Payable $4.68M $5.35M $2.32M $5.00M $4.46M $3.42M $3.45M $2.85M
Deferred Revenue (Current) $2.05M $1.88M $1.71M $1.56M $1.34M $1.14M $949K $939K
Total Current Liabilities $32.84M $26.02M $23.19M $30.92M $25.39M $19.49M $16.49M $21.15M
Deferred Revenue (Non-Current) $3.48M $3.45M $3.35M $3.30M $2.99M $2.67M $2.33M $1.86M
Other Non-Current Liabilities $1.41M $1.63M $1.56M $1.55M $1.21M $1.01M -- --
Total Non-Current Liabilities $9.54M $10.00M $9.98M $10.21M $9.90M $8.85M $7.78M $52.48M
Total Liabilities $42.38M $36.02M $33.17M $41.13M $35.29M $28.34M $24.27M $73.63M
Total Debt (incl. Leases) $6.10M $6.51M $6.91M $7.30M $7.69M $6.69M $6.97M $7.25M
Common Stock $5.0K $5.0K $5.0K $4.0K $4.0K $4.0K $4.0K $1.0K
Retained Earnings -$439.6M -$415.2M -$391.8M -$369.9M -$356.5M -$342.3M -$325.4M -$296.7M
Accumulated Other Comp. Income -$877K -$390K -$96K $403K $354K $149K $240K $65K
Total Stockholders' Equity $401.4M $256.4M $271.2M $287.6M $294.8M $301.6M $313.8M -$245.4M
Total Equity $401.4M $256.4M $271.2M $287.6M $294.8M $301.6M $313.8M -$245.4M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31
Net Income -$73.20M -$54.76M -$44.10M
Depreciation & Amortization $1.57M $1.15M $1.23M
Stock-Based Compensation $16.38M $6.38M $5.66M
Change in Receivables -$5.16M -$7.62M -$4.49M
Change in Inventory -$9.88M -$11.44M -$1.19M
Change in Payables $2.10M $1.51M $716K
Operating Cash Flow -$50.92M -$48.27M -$32.45M
Capital Expenditure -$5.30M -$3.40M -$402K
Free Cash Flow -$56.22M -$51.67M -$32.85M
Investing Cash Flow -$162.8M -$3.48M -$69.69M
Common Stock Issued $194.5M -- --
Financing Cash Flow $214.9M $55.62M $101.0M
Net Change in Cash $1.14M $3.87M -$1.11M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$24.35M -$23.40M -$21.89M -$13.47M -$14.21M -$16.87M -$28.66M -$18.11M
Depreciation & Amortization $892K $709K $585K $538K $385K $347K $303K $232K
Stock-Based Compensation $6.71M $7.02M $5.41M $4.30M $4.48M $4.80M $2.80M $1.55M
Change in Receivables -$2.65M -$2.32M $1.37M -$5.59M -$168K -$2.33M $2.94M -$4.56M
Change in Inventory $1.33M -$214K -$1.80M -$2.20M -$3.33M -$1.73M -$2.62M -$1.21M
Change in Payables -$352K $2.86M -$3.33M $527K $1.10M $568K -$97K -$61K
Operating Cash Flow -$12.29M -$14.62M -$23.83M -$8.63M -$8.73M -$13.59M -$19.98M -$14.28M
Capital Expenditure -$2.27M -$1.04M -$1.38M -$1.90M -$1.28M -$1.78M -$333K -$561K
Free Cash Flow -$14.56M -$15.66M -$25.21M -$10.53M -$10.01M -$15.37M -$20.31M -$14.84M
Investing Cash Flow -$114.1M $26.93M $21.84M $658K $9.49M $6.17M -$179.1M -$29.66M
Common Stock Issued -- -- -- -$904K $0 $0 $195.4M --
Financing Cash Flow $163.6M $1.80M $623K $1.06M $2.65M $42K $211.1M $56.89M
Net Change in Cash $37.23M $14.11M -$1.37M -$6.91M $3.41M -$7.38M $12.02M $12.95M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31
Gross Margin 55.4% 55.1% 52.6%
Operating Margin -71.5% -69.5% -298.9%
Net Profit Margin -73.0% -84.1% -367.6%
Return on Equity (ROE) -25.5% -- --
Return on Assets (ROA) -22.3% -36.6% -40.1%
Current Ratio 8.66x 6.29x 9.77x
Quick Ratio 7.96x 5.66x 9.65x
Debt to Equity 0.03x -- --
Revenue Growth (YoY) +53.9% +442.9% --
Gross Profit Growth (YoY) +54.8% +468.9% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 58.6% 58.3% 57.2% 55.4% 54.5% 53.9% 53.9% 55.1%
Operating Margin -72.7% -69.8% -70.1% -71.5% -77.4% -80.1% -78.0% -69.5%
Net Profit Margin -65.3% -61.3% -60.3% -73.0% -87.9% -94.0% -101.6% -84.1%
Return on Equity (ROE) -20.7% -28.5% -24.5% -25.5% -26.4% -24.3% -22.6% --
Return on Assets (ROA) -18.7% -25.0% -21.8% -22.3% -23.6% -22.2% -21.0% -36.6%
Current Ratio 8.92x 8.88x 10.69x 8.66x 10.64x 14.68x 15.88x 6.29x
Quick Ratio 8.22x 7.96x 9.67x 7.96x 9.83x 13.79x 14.93x 5.66x
Debt to Equity 0.02x 0.03x 0.03x 0.03x 0.03x 0.02x 0.02x --
Revenue Growth (YoY) +30.3% +37.8% +56.6% +57.1% +63.1% +54.4% +36.4% --
Gross Profit Growth (YoY) +34.5% +51.2% +83.2% +62.1% +69.6% +54.7% +24.6% --
Source: SEC EDGAR CompanyFacts (CIK 0001674632) · from December 31, 2023 Data through September 30, 2026 · synced Nov 20, 2026, 05:33 UTC · Open in terminal